CN Patent

CN111303230B — 一种黄体酮共晶物及其制备方法和用途

Assigned to National Institutes for Food and Drug Control · Expires 2021-07-13 · 5y expired

What this patent protects

本发明涉及一种黄体酮共晶物，其由活性成分黄体酮和共晶形成物形成，其中所述共晶形成物选自间苯二甲酸、4‑甲酰苯硼酸或3‑硝基邻苯二甲酸。本发明还涉及所述黄体酮共晶物的制备方法及其用于增加子宫内膜厚度、改善黄体酮溶解性或提高黄体酮渗透速率的用途。

USPTO Abstract

本发明涉及一种黄体酮共晶物，其由活性成分黄体酮和共晶形成物形成，其中所述共晶形成物选自间苯二甲酸、4‑甲酰苯硼酸或3‑硝基邻苯二甲酸。本发明还涉及所述黄体酮共晶物的制备方法及其用于增加子宫内膜厚度、改善黄体酮溶解性或提高黄体酮渗透速率的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN111303230B
Jurisdiction
CN
Classification
—
Expires
2021-07-13
Drug substance claim
No
Drug product claim
No
Assignee
National Institutes for Food and Drug Control
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.